Sonoma Pharmaceuticals Inc (SNOA)
0.156
0.00 (0.00%)
USD |
NASDAQ |
May 06, 09:47
Sonoma Pharmaceuticals Price to Book Value: 0.3638 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.3638 |
| May 02, 2024 | 0.3571 |
| May 01, 2024 | 0.3573 |
| April 30, 2024 | 0.3706 |
| April 29, 2024 | 0.3734 |
| April 26, 2024 | 0.3708 |
| April 25, 2024 | 0.3741 |
| April 24, 2024 | 0.3732 |
| April 23, 2024 | 0.3708 |
| April 22, 2024 | 0.3671 |
| April 19, 2024 | 0.3498 |
| April 18, 2024 | 0.3652 |
| April 17, 2024 | 0.3921 |
| April 16, 2024 | 0.3872 |
| April 15, 2024 | 0.3764 |
| April 12, 2024 | 0.4093 |
| April 11, 2024 | 0.3916 |
| April 10, 2024 | 0.4021 |
| April 09, 2024 | 0.3643 |
| April 08, 2024 | 0.3426 |
| April 05, 2024 | 0.3552 |
| April 04, 2024 | 0.3739 |
| April 03, 2024 | 0.3685 |
| April 02, 2024 | 0.3382 |
| April 01, 2024 | 0.3573 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.3879 |
| March 27, 2024 | 0.3851 |
| March 26, 2024 | 0.3685 |
| March 25, 2024 | 0.3265 |
| March 22, 2024 | 0.3288 |
| March 21, 2024 | 0.3125 |
| March 20, 2024 | 0.3191 |
| March 19, 2024 | 0.3382 |
| March 18, 2024 | 0.3242 |
| March 15, 2024 | 0.3202 |
| March 14, 2024 | 0.3146 |
| March 13, 2024 | 0.3195 |
| March 12, 2024 | 0.3265 |
| March 11, 2024 | 0.3475 |
| March 08, 2024 | 0.3592 |
| March 07, 2024 | 0.3589 |
| March 06, 2024 | 0.361 |
| March 05, 2024 | 0.3662 |
| March 04, 2024 | 0.3498 |
| March 01, 2024 | 0.3615 |
| February 29, 2024 | 0.3428 |
| February 28, 2024 | 0.334 |
| February 27, 2024 | 0.3414 |
| February 26, 2024 | 0.3498 |
| February 23, 2024 | 0.3405 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1623
Minimum
Oct 27 2023
4.077
Maximum
Sep 28 2021
1.182
Average
0.9698
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.986 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.1800 |
| Oragenics Inc | 3.072 |
Price to Book Value Related Metrics
| PS Ratio | 0.0801 |
| Price | 0.156 |
| Earnings Yield | -602.6% |
| Market Cap | 2.435M |